{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:31:51Z","timestamp":1788280311646,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Medulloblastomas (MBs) are aggressive brain cancers and represent the most common primary malignant tumour in children. Current treatment protocols involve an intensive regimen of surgery, radiation therapy and chemotherapy, guided by histopathology and risk stratification. Unfortunately, disease relapse proves fatal in 30% of cases, and treatment efficacy is compromised as MB cells develop resistance. Therefore, there is a critical need for more effective and tolerable therapies, especially for the treatment of aggressive MBs associated with a poor prognosis. Lipid metabolism reprogramming, characterized by increased cholesterol synthesis, lipid uptake and the activation of de novo lipogenesis, is a newly identified hallmark of cancers. Cholesterol is an essential structural component of membranes that contributes to membrane integrity and fluidity. Recently, increasing evidence has indicated that cholesterol is a major determinant by modulating cell signalling events governing the hallmarks of cancer. Our research demonstrates there is an overexpression of cholesterol metabolism in group 3 (G3), and group 4 (G4) MB subgroups compared to Sonic Hedgehog (SHH)-MB subgroup. In these tumours, cholesterol metabolism supports cell migration through the Rho-GTPase signalling pathway. Notably, we observed that shifting the culture conditions from 2D to 3D significantly upregulates lipid metabolism. Furthermore, spheroids derived from G3\/G4-MBs and SHH-MBs show similar sensitivity to low doses of simvastatin. We validated these findings in a xenograft mouse model, where treatment with low doses of simvastatin led to increased survival time and remarkably, also reduced the metastatic spread of MB cells to the spinal cord. These results suggest that simvastatin holds potential as an adjuvant treatment for patients with medulloblastoma.<\/jats:p>","DOI":"10.1038\/s41419-025-07829-0","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:49:51Z","timestamp":1752612591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Simvastatin suppresses spinal cord metastasis of medulloblastoma at clinically significant doses"],"prefix":"10.1038","volume":"16","author":[{"given":"Charley","family":"Comer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5551-9412","authenticated-orcid":false,"given":"Kian","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8407-8336","authenticated-orcid":false,"given":"Sara","family":"Badodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Buccafusca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Peet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5664-9135","authenticated-orcid":false,"given":"Alice","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4187-405X","authenticated-orcid":false,"given":"David","family":"Michod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bochukova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2147-370X","authenticated-orcid":false,"given":"Maria Victoria","family":"Niklison-Chirou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"7829_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s13311-017-0526-y","volume":"14","author":"TC Archer","year":"2017","unstructured":"Archer TC, Mahoney EL, Pomeroy SL. Medulloblastoma: molecular classification-based personal therapeutics. Neurotherapeutics. 2017;14:265\u201373.","journal-title":"Neurotherapeutics"},{"key":"7829_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803\u201320.","journal-title":"Acta Neuropathol"},{"key":"7829_CR3","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1200\/JCO.2012.48.5052","volume":"31","author":"N Zhukova","year":"2013","unstructured":"Zhukova N, Ramaswamy V, Remke M, Pfaff E, Shih DJ, Martin DC, et al. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol. 2013;31:2927\u201335.","journal-title":"J Clin Oncol"},{"key":"7829_CR4","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/acn3.762","volume":"6","author":"O Menyhart","year":"2019","unstructured":"Menyhart O, Gyorffy B. Principles of tumorigenesis and emerging molecular drivers of SHH-activated medulloblastomas. Ann Clin Transl Neurol. 2019;6:990\u20131005.","journal-title":"Ann Clin Transl Neurol"},{"key":"7829_CR5","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ccell.2016.03.002","volume":"29","author":"TN Phoenix","year":"2016","unstructured":"Phoenix TN, Patmore DM, Boop S, Boulos N, Jacus MO, Patel YT, et al. Medulloblastoma genotype dictates blood brain barrier phenotype. Cancer Cell. 2016;29:508\u201322.","journal-title":"Cancer Cell"},{"key":"7829_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00401-012-0958-8","volume":"123","author":"M Kool","year":"2012","unstructured":"Kool M, Korshunov A, Remke M, Jones DT, Schlanstein M, Northcott PA, et al. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol. 2012;123:473\u201384.","journal-title":"Acta Neuropathol"},{"key":"7829_CR7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00401-011-0922-z","volume":"123","author":"MD Taylor","year":"2012","unstructured":"Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC, et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 2012;123:465\u201372.","journal-title":"Acta Neuropathol"},{"key":"7829_CR8","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1200\/JCO.2010.30.2810","volume":"29","author":"DW Ellison","year":"2011","unstructured":"Ellison DW, Kocak M, Dalton J, Megahed H, Lusher ME, Ryan SL, et al. Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables. J Clin Oncol. 2011;29:1400\u20137.","journal-title":"J Clin Oncol"},{"key":"7829_CR9","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/02688690903121807","volume":"23","author":"BL Pizer","year":"2009","unstructured":"Pizer BL, Clifford SC. The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials. Br J Neurosurg. 2009;23:364\u201375.","journal-title":"Br J Neurosurg"},{"key":"7829_CR10","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-016-1569-6","volume":"131","author":"V Ramaswamy","year":"2016","unstructured":"Ramaswamy V, Remke M, Bouffet E, Bailey S, Clifford SC, Doz F, et al. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. Acta Neuropathol. 2016;131:821\u201331.","journal-title":"Acta Neuropathol"},{"key":"7829_CR11","doi-asserted-by":"crossref","unstructured":"Zahnreich S, Schmidberger H. Childhood cancer: occurrence, treatment and risk of second primary malignancies. Cancers. 2021;13:2607.","DOI":"10.3390\/cancers13112607"},{"key":"7829_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/2051-5960-2-57","volume":"2","author":"RT Othman","year":"2014","unstructured":"Othman RT, Kimishi I, Bradshaw TD, Storer LC, Korshunov A, Pfister SM, et al. Overcoming multiple drug resistance mechanisms in medulloblastoma. Acta Neuropathol Commun. 2014;2:57.","journal-title":"Acta Neuropathol Commun"},{"key":"7829_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956;123:309\u201314.","journal-title":"Science"},{"key":"7829_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/biof.31","volume":"35","author":"R Moreno-S\u00e1nchez","year":"2009","unstructured":"Moreno-S\u00e1nchez R, Rodr\u00edguez-Enr\u00edquez S, Saavedra E, Mar\u00edn-Hern\u00e1ndez A, Gallardo-P\u00e9rez JC. The bioenergetics of cancer: is glycolysis the main ATP supplier in all tumor cells?. Biofactors. 2009;35:209\u201325.","journal-title":"Biofactors"},{"key":"7829_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/343425a0","volume":"343","author":"JL Goldstein","year":"1990","unstructured":"Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature. 1990;343:425\u201330.","journal-title":"Nature"},{"key":"7829_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.clinbiochem.2007.03.016","volume":"40","author":"I Buhaescu","year":"2007","unstructured":"Buhaescu I, Izzedine H. Mevalonate pathway: a review of clinical and therapeutical implications. Clin Biochem. 2007;40:575\u201384.","journal-title":"Clin Biochem"},{"key":"7829_CR17","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1158\/1078-0432.CCR-12-0489","volume":"18","author":"M Thurnher","year":"2012","unstructured":"Thurnher M, Nussbaumer O, Gruenbacher G. Novel aspects of mevalonate pathway inhibitors as antitumor agents. Clin Cancer Res. 2012;18:3524\u201331.","journal-title":"Clin Cancer Res"},{"key":"7829_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nature01148","volume":"420","author":"S Etienne-Manneville","year":"2002","unstructured":"Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature. 2002;420:629\u201335.","journal-title":"Nature"},{"key":"7829_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114623","volume":"196","author":"MA Lasuncion","year":"2022","unstructured":"Lasuncion MA, Martinez-Botas J, Martin-Sanchez C, Busto R, Gomez-Coronado D. Cell cycle dependence on the mevalonate pathway: role of cholesterol and non-sterol isoprenoids. Biochem Pharm. 2022;196:114623.","journal-title":"Biochem Pharm"},{"key":"7829_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9274016","volume":"2020","author":"H Al-Koussa","year":"2020","unstructured":"Al-Koussa H, Atat OE, Jaafar L, Tashjian H, El-Sibai M. The role of Rho GTPases in motility and invasion of glioblastoma cells. Anal Cell Pathol. 2020;2020:9274016.","journal-title":"Anal Cell Pathol"},{"key":"7829_CR21","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.gendis.2020.11.009","volume":"9","author":"X Du","year":"2022","unstructured":"Du X, Ou Y, Zhang M, Li K, Huang W, Jiang D. The mevalonate pathway promotes the metastasis of osteosarcoma by regulating YAP1 activity via RhoA. Genes Dis. 2022;9:741\u201352.","journal-title":"Genes Dis"},{"key":"7829_CR22","doi-asserted-by":"crossref","unstructured":"Ortiz N, D\u00edaz C. Mevalonate pathway as a novel target for the treatment of metastatic gastric cancer. Oncol Lett. 2020;20:320.","DOI":"10.3892\/ol.2020.12183"},{"key":"7829_CR23","doi-asserted-by":"publisher","first-page":"16067","DOI":"10.3390\/ijms160716067","volume":"16","author":"PM Tricarico","year":"2015","unstructured":"Tricarico PM, Crovella S, Celsi F. Mevalonate pathway blockade, mitochondrial dysfunction and autophagy: a possible link. Int J Mol Sci. 2015;16:16067\u201384.","journal-title":"Int J Mol Sci"},{"key":"7829_CR24","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nrc1751","volume":"5","author":"MF Demierre","year":"2005","unstructured":"Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman SM. Statins and cancer prevention. Nat Rev Cancer. 2005;5:930\u201342.","journal-title":"Nat Rev Cancer"},{"key":"7829_CR25","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2174\/156800905774932824","volume":"5","author":"J Dulak","year":"2005","unstructured":"Dulak J, Jozkowicz A. Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy. Curr Cancer Drug Targets. 2005;5:579\u201394.","journal-title":"Curr Cancer Drug Targets"},{"key":"7829_CR26","doi-asserted-by":"crossref","unstructured":"Sheikholeslami K, Ali Sher A, Lockman S, Kroft D, Ganjibakhsh M, Nejati-Koshki K, et al. Simvastatin induces apoptosis in medulloblastoma brain tumor cells via mevalonate cascade prenylation substrates. Cancers. 2019;11:994.","DOI":"10.3390\/cancers11070994"},{"key":"7829_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/srep35783","volume":"6","author":"G Wang","year":"2016","unstructured":"Wang G, Cao R, Wang Y, Qian G, Dan HC, Jiang W, et al. Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARgamma signalling pathway. Sci Rep. 2016;6:35783.","journal-title":"Sci Rep"},{"key":"7829_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2051-5960-2-10","volume":"2","author":"A Merve","year":"2014","unstructured":"Merve A, Dubuc AM, Zhang X, Remke M, Baxter PA, Li XN, et al. Polycomb group gene BMI1 controls invasion of medulloblastoma cells and inhibits BMP-regulated cell adhesion. Acta Neuropathol Commun. 2014;2:10.","journal-title":"Acta Neuropathol Commun"},{"key":"7829_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fcell.2019.00107","volume":"7","author":"J Pijuan","year":"2019","unstructured":"Pijuan J, Barcelo C, Moreno DF, Maiques O, Siso P, Marti RM, et al. In vitro cell migration, invasion, and adhesion assays: from cell imaging to data analysis. Front Cell Dev Biol. 2019;7:107.","journal-title":"Front Cell Dev Biol"},{"key":"7829_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.357","volume":"2","author":"SJ Roper","year":"2022","unstructured":"Roper SJ, Coyle B. Establishing an in vitro 3D spheroid model to study medulloblastoma drug response and tumor dissemination. Curr Protoc. 2022;2:e357.","journal-title":"Curr Protoc"},{"key":"7829_CR31","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-15-2402","volume":"76","author":"CG Hubert","year":"2016","unstructured":"Hubert CG, Rivera M, Spangler LC, Wu Q, Mack SC, Prager BC, et al. A three-dimensional organoid culture system derived from human glioblastomas recapitulates the hypoxic gradients and cancer stem cell heterogeneity of tumors found in vivo. Cancer Res. 2016;76:2465\u201377.","journal-title":"Cancer Res"},{"key":"7829_CR32","doi-asserted-by":"publisher","first-page":"e46214","DOI":"10.1371\/journal.pone.0046214","volume":"7","author":"DF Peng","year":"2012","unstructured":"Peng DF, Hu TL, Schneider BG, Chen Z, Xu ZK, El-Rifai W. Silencing of glutathione peroxidase 3 through DNA hypermethylation is associated with lymph node metastasis in gastric carcinomas. PLoS ONE. 2012;7:e46214.","journal-title":"PLoS ONE"},{"key":"7829_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/path.4813","volume":"241","author":"JC Chiang","year":"2017","unstructured":"Chiang JC, Ellison DW. Molecular pathology of paediatric central nervous system tumours. J Pathol. 2017;241:159\u201372.","journal-title":"J Pathol"},{"key":"7829_CR34","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s00018-022-04504-x","volume":"79","author":"M Wei","year":"2022","unstructured":"Wei M, Nurjanah U, Herkilini A, Huang C, Li Y, Miyagishi M, et al. Unspliced XBP1 contributes to cholesterol biosynthesis and tumorigenesis by stabilizing SREBP2 in hepatocellular carcinoma. Cell Mol Life Sci. 2022;79:472.","journal-title":"Cell Mol Life Sci"},{"key":"7829_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/jmri.28007","volume":"56","author":"RJ Dury","year":"2022","unstructured":"Dury RJ, Lourdusamy A, Macarthur DC, Peet AC, Auer DP, Grundy RG, et al. Meta-analysis of apparent diffusion coefficient in pediatric medulloblastoma, ependymoma, and pilocytic astrocytoma. J Magn Reson Imaging. 2022;56:147\u201357.","journal-title":"J Magn Reson Imaging"},{"key":"7829_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165968","volume":"1866","author":"M Ahmadi","year":"2020","unstructured":"Ahmadi M, Amiri S, Pecic S, Machaj F, Rosik J, Los MJ, et al. Pleiotropic effects of statins: a focus on cancer. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165968.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"7829_CR37","doi-asserted-by":"publisher","first-page":"33175","DOI":"10.1074\/jbc.272.52.33175","volume":"272","author":"PS Backlund Jr","year":"1997","unstructured":"Backlund PS Jr. Post-translational processing of RhoA. Carboxyl methylation of the carboxyl-terminal prenylcysteine increases the half-life of Rhoa. J Biol Chem. 1997;272:33175\u201380.","journal-title":"J Biol Chem"},{"key":"7829_CR38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0955-0674(97)80156-1","volume":"9","author":"N Tapon","year":"1997","unstructured":"Tapon N, Hall A. Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr Opin Cell Biol. 1997;9:86\u201392.","journal-title":"Curr Opin Cell Biol"},{"key":"7829_CR39","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1073\/pnas.87.8.3042","volume":"87","author":"JH Jackson","year":"1990","unstructured":"Jackson JH, Cochrane CG, Bourne JR, Solski PA, Buss JE, Der CJ. Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation. Proc Natl Acad Sci USA. 1990;87:3042\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7829_CR40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0898-6568(97)00120-4","volume":"10","author":"MC Seabra","year":"1998","unstructured":"Seabra MC. Membrane association and targeting of prenylated Ras-like GTPases. Cell Signal. 1998;10:167\u201372.","journal-title":"Cell Signal"},{"key":"7829_CR41","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/bcp.13539","volume":"84","author":"SB Dimmitt","year":"2018","unstructured":"Dimmitt SB, Stampfer HG, Warren JB. The pharmacodynamic and clinical trial evidence for statin dose. Br J Clin Pharm. 2018;84:1128\u201335.","journal-title":"Br J Clin Pharm"},{"key":"7829_CR42","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"7829_CR43","doi-asserted-by":"crossref","unstructured":"Li JQ, Eu JQ, Kong LR, Wang LZ, Lim YC, Goh BC, et al. Targeting metabolism in cancer cells and the tumour microenvironment for cancer therapy. Molecules. 2020;25:4831.","DOI":"10.3390\/molecules25204831"},{"key":"7829_CR44","doi-asserted-by":"publisher","first-page":"29487","DOI":"10.18632\/oncotarget.15494","volume":"8","author":"ME Monaco","year":"2017","unstructured":"Monaco ME. Fatty acid metabolism in breast cancer subtypes. Oncotarget. 2017;8:29487\u2013500.","journal-title":"Oncotarget"},{"key":"7829_CR45","doi-asserted-by":"publisher","first-page":"4151-+","DOI":"10.1200\/JCO.2016.67.2428","volume":"34","author":"AO von Bueren","year":"2016","unstructured":"von Bueren AO, Kortmann RD, von Hoff K, Friedrich C, Mynarek M, M\u00fcller K, et al. Treatment of children and adolescents with metastatic medulloblastoma and prognostic relevance of clinical and biologic parameters. J Clin Oncol. 2016;34:4151-+.","journal-title":"J Clin Oncol"},{"key":"7829_CR46","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2217\/cns.13.30","volume":"2","author":"D Aref","year":"2013","unstructured":"Aref D, Croul S. Medulloblastoma: recurrence and metastasis. CNS Oncol. 2013;2:377\u201385.","journal-title":"CNS Oncol"},{"key":"7829_CR47","doi-asserted-by":"publisher","first-page":"10345","DOI":"10.18632\/oncotarget.7213","volume":"7","author":"U Walther","year":"2016","unstructured":"Walther U, Emmrich K, Ramer R, Mittag N, Hinz B. Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2\/PPAR gamma-dependent pathway. Oncotarget. 2016;7:10345\u201362.","journal-title":"Oncotarget"},{"key":"7829_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.574068","volume":"11","author":"L Yin","year":"2020","unstructured":"Yin L, He Z, Yi B, Xue L, Sun J. Simvastatin suppresses human breast cancer cell invasion by decreasing the expression of pituitary tumor-transforming gene 1. Front Pharm. 2020;11:574068.","journal-title":"Front Pharm"},{"key":"7829_CR49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.canlet.2018.09.028","volume":"439","author":"VK Gupta","year":"2018","unstructured":"Gupta VK, Sharma NS, Kesh K, Dauer P, Nomura A, Giri B, et al. Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity. Cancer Lett. 2018;439:101\u201312.","journal-title":"Cancer Lett"},{"key":"7829_CR50","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.bbalip.2017.12.006","volume":"1863","author":"E Jarc","year":"2018","unstructured":"Jarc E, Kump A, Malavasic P, Eichmann TO, Zimmermann R, Petan T. Lipid droplets induced by secreted phospholipase A(2) and unsaturated fatty acids protect breast cancer cells from nutrient and lipotoxic stress. Biochim Biophys Acta Mol Cell Biol Lipids. 2018;1863:247\u201365.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"7829_CR51","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41568-018-0048-x","volume":"18","author":"BT Finicle","year":"2018","unstructured":"Finicle BT, Jayashankar V, Edinger AL. Nutrient scavenging in cancer. Nat Rev Cancer. 2018;18:619\u201333.","journal-title":"Nat Rev Cancer"},{"key":"7829_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14928-3","volume":"11","author":"V Jayashankar","year":"2020","unstructured":"Jayashankar V, Edinger AL. Macropinocytosis confers resistance to therapies targeting cancer anabolism. Nat Commun. 2020;11:1121.","journal-title":"Nat Commun"},{"key":"7829_CR53","doi-asserted-by":"crossref","unstructured":"Petan T. Lipid droplets in cancer. Rev Physiol Biochem Pharmacol. 2023;185:53\u201386.","DOI":"10.1007\/112_2020_51"},{"key":"7829_CR54","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2174\/1574892812666171129141211","volume":"13","author":"F Iannelli","year":"2018","unstructured":"Iannelli F, Lombardi R, Milone MR, Pucci B, De Rienzo S, Budillon A, et al. Targeting mevalonate pathway in cancer treatment: repurposing of statins. Recent Pat Anticancer Drug Discov. 2018;13:184\u2013200.","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"7829_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811X-8-23","volume":"8","author":"M Parri","year":"2010","unstructured":"Parri M, Chiarugi P. Rac and Rho GTPases in cancer cell motility control. Cell Commun Signal. 2010;8:23.","journal-title":"Cell Commun Signal"},{"key":"7829_CR56","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1002\/cac2.12502","volume":"43","author":"X Cui","year":"2023","unstructured":"Cui X, Zhao J, Li G, Yang C, Yang S, Zhan Q, et al. Blockage of EGFR\/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma. Cancer Commun. 2023;43:1326\u201353.","journal-title":"Cancer Commun"},{"key":"7829_CR57","doi-asserted-by":"crossref","unstructured":"Taylor L, Wade PK, Johnson JEC, Aldighieri M, Morlando S, Di Leva G, et al. Drug resistance in medulloblastoma is driven by YB-1, ABCB1 and a seven-gene drug signature. Cancers. 2023;15:1086.","DOI":"10.3390\/cancers15041086"},{"key":"7829_CR58","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/path.5591","volume":"253","author":"F Linke","year":"2021","unstructured":"Linke F, Aldighieri M, Lourdusamy A, Grabowska AM, Stolnik S, Kerr ID, et al. 3D hydrogels reveal medulloblastoma subgroup differences and identify extracellular matrix subtypes that predict patient outcome. J Pathol. 2021;253:326\u201338.","journal-title":"J Pathol"},{"key":"7829_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83809-6","volume":"11","author":"SJ Roper","year":"2021","unstructured":"Roper SJ, Linke F, Scotting PJ, Coyle B. 3D spheroid models of paediatric SHH medulloblastoma mimic tumour biology, drug response and metastatic dissemination. Sci Rep. 2021;11:4259.","journal-title":"Sci Rep"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07829-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07829-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07829-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T12:37:13Z","timestamp":1757248633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07829-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7829"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07829-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures had Home Office approval (Animals Scientific Procedures Act 1986, PPL 70\/7275) and approved by QMUL ethical review committees. All methods were performed in accordance with the relevant guidelines and regulations, and approved by QMUL ethical review committees. All patients and\/or legal guardians provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}],"article-number":"527"}}